Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Cancer
2		Interventions listed in this trial
			recombinant interleukin-12
			trastuzumab
3		Additional drug interventions recognized in this trial
			Interleukin-12
4		More general drug interventions related to this trial
			Adjuvants, Immunologic
			Angiogenesis Inhibitors
			Angiogenesis Modulating Agents
			Antineoplastic Agents
			Growth Inhibitors
			Growth Substances
			Immunologic Factors
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
5		Sponsors listed in this trial
			Arthur G. James Cancer Hospital &Richard J. Solove Research Institute
			National Cancer Institute (NCI)